It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Highlights
Vapor nanobubble (VNB) photoporation represents a promising physical technique for mRNA transfection of adherent and suspension cells.
A multitude of parameters related to the VNB photoporation procedure were optimized to enable efficient mRNA transfection.
VNB photoporation was found to yield five times more living, transfected Jurkat T cells as compared to electroporation, i.e., currently the standard nonviral transfection technique for T cells.
Efficient and safe cell engineering by transfection of nucleic acids remains one of the long-standing hurdles for fundamental biomedical research and many new therapeutic applications, such as CAR T cell-based therapies. mRNA has recently gained increasing attention as a more safe and versatile alternative tool over viral- or DNA transposon-based approaches for the generation of adoptive T cells. However, limitations associated with existing nonviral mRNA delivery approaches hamper progress on genetic engineering of these hard-to-transfect immune cells. In this study, we demonstrate that gold nanoparticle-mediated vapor nanobubble (VNB) photoporation is a promising upcoming physical transfection method capable of delivering mRNA in both adherent and suspension cells. Initial transfection experiments on HeLa cells showed the importance of transfection buffer and cargo concentration, while the technology was furthermore shown to be effective for mRNA delivery in Jurkat T cells with transfection efficiencies up to 45%. Importantly, compared to electroporation, which is the reference technology for nonviral transfection of T cells, a fivefold increase in the number of transfected viable Jurkat T cells was observed. Altogether, our results point toward the use of VNB photoporation as a more gentle and efficient technology for intracellular mRNA delivery in adherent and suspension cells, with promising potential for the future engineering of cells in therapeutic and fundamental research applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Ghent University, Laboratory of General Biochemistry & Physical Pharmacy, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0)
2 Ghent University, Laboratory of General Biochemistry & Physical Pharmacy, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
3 Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0); Ghent University, Department of Diagnostic Sciences, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
4 Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0); VIB-UGent Center for Medical Biotechnology, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040); Ghent University, Department of Biomedical Molecular Biology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
5 VIB-UGent Center for Medical Biotechnology, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040); Ghent University, Department of Biochemistry and Microbiology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)